Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Macadam

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Infectious Diseases|October 18, 2023
The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype PathogensRaul Andino, Karla Kirkegaard, Andrew Macadam, et al.
Vaccines|September 23, 2022
Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus VaccineHasmik Manukyan, Rahnuma Wahid, Azeem Ansari, et al.
Cell|March 25, 2017
The Evolutionary Pathway to Virulence of an RNA VirusAdi Stern, Ming Te Yeh, Tal Zinger, et al.
Nature|June 14, 2023
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3Ming Te Yeh, Matthew Smith, Sarah Carlyle, et al.
The Journal of General Virology|August 23, 2022
Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsidsNatalie J Kingston, Mona Shegdar, Joseph S Snowden, et al.
Mbio|December 12, 2024
Non-lytic spread of poliovirus requires the nonstructural protein 3CDDavid Aponte-Diaz, Jayden M Harris, Tongjia Ella Kang, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Non-lytic spread of poliovirus requires the nonstructural protein 3CDDavid Aponte-Diaz, Jayden M Harris, Tongjia Ella Kang, et al.
Cell Host & Microbe|April 25, 2020
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceMing Te Yeh, Erika Bujaki, Patrick T Dolan, et al.
The Journal of Infectious Diseases|March 20, 2004
Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in HispaniolaJan Vinjé, Nicole Gregoricus, Javier Martin, et al.
Vaccine|November 4, 2015
Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPVBarbara P Sanders, Isabel de los Rios Oakes, Vladimir van Hoek, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|October 18, 2023
The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype PathogensRaul Andino, Karla Kirkegaard, Andrew Macadam, et al.
Vaccines|September 23, 2022
Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus VaccineHasmik Manukyan, Rahnuma Wahid, Azeem Ansari, et al.
Cell|March 25, 2017
The Evolutionary Pathway to Virulence of an RNA VirusAdi Stern, Ming Te Yeh, Tal Zinger, et al.
Nature|June 14, 2023
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3Ming Te Yeh, Matthew Smith, Sarah Carlyle, et al.
The Journal of General Virology|August 23, 2022
Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsidsNatalie J Kingston, Mona Shegdar, Joseph S Snowden, et al.
Mbio|December 12, 2024
Non-lytic spread of poliovirus requires the nonstructural protein 3CDDavid Aponte-Diaz, Jayden M Harris, Tongjia Ella Kang, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Non-lytic spread of poliovirus requires the nonstructural protein 3CDDavid Aponte-Diaz, Jayden M Harris, Tongjia Ella Kang, et al.
Cell Host & Microbe|April 25, 2020
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceMing Te Yeh, Erika Bujaki, Patrick T Dolan, et al.
The Journal of Infectious Diseases|March 20, 2004
Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in HispaniolaJan Vinjé, Nicole Gregoricus, Javier Martin, et al.
Vaccine|November 4, 2015
Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPVBarbara P Sanders, Isabel de los Rios Oakes, Vladimir van Hoek, et al.
Pageof 2